Home Cart Sign in  
Chemical Structure| 146949-21-5 Chemical Structure| 146949-21-5

Structure of Pocapavir
CAS No.: 146949-21-5

Chemical Structure| 146949-21-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pocapavir (SCH-48973) is an orally bioavailable capsid inhibitor that prevents viral uncoating after cell entry. It exhibits antiviral activity against poliovirus and can inhibit enterovirus infections.

Synonyms: SCH-48973; V-073; V074

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pocapavir

CAS No. :146949-21-5
Formula : C21H17Cl3O3
M.W : 423.72
SMILES Code : COC1=CC=C(OCC2=CC=C(C=C2)COC3=C(Cl)C=CC=C3Cl)C(Cl)=C1
Synonyms :
SCH-48973; V-073; V074
MDL No. :MFCD00950032

Safety of Pocapavir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BGMK cells 0.02 to 0.11 µg/ml 18 to 24 hours To evaluate the inhibitory effect of SCH 48973 on echoviruses, results showed significant antiviral activity. Antimicrob Agents Chemother. 1997 Jun;41(6):1220-5
HeLa cells 0.02 to 0.11 µg/ml 18 to 24 hours To evaluate the inhibitory effect of SCH 48973 on the cytopathic effect of five picornaviruses, results showed significant antiviral activity with no cytotoxicity. Antimicrob Agents Chemother. 1997 Jun;41(6):1220-5
RD cells 0.9 µg/ml 2 to 3 days To assess the antiviral spectrum of SCH 48973 against various enteroviruses, results showed inhibition against 80% of the virus strains. Antimicrob Agents Chemother. 1997 Jun;41(6):1220-5

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Mouse poliovirus model Oral 3 to 20 mg/kg/day Three times daily for 21 days To evaluate the therapeutic efficacy of SCH 48973 in a mouse poliovirus model, results showed significant improvement in survival and reduction in brain viral titers. Antimicrob Agents Chemother. 1997 Jun;41(6):1220-5

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.36mL

0.47mL

0.24mL

11.80mL

2.36mL

1.18mL

23.60mL

4.72mL

2.36mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories